137421-58-0

Basic information

• Product Name: 3-[4-((1-carbomethoxy-1-phenyl)methoxy)-3,5-dipropylphenylmethyl]-5,7-dimethyl-2-ethyl-3H-imidazo-[4,5-b]pyridine
• Synonyms: 3-[4-((1-carbomethoxy-1-phenyl)methoxy)-3,5-dipropylphenylmethyl]-5,7-dimethyl-2-ethyl-3H-imidazo-[4,5-b]pyridine
• CAS NO: 137421-58-0
• Molecular Weight: 513.68
• Mol File: 137421-58-0.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 3-[4-((1-carbomethoxy-1-phenyl)methoxy)-3,5-dipropylphenylmethyl]-5,7-dimethyl-2-ethyl-3H-imidazo-[4,5-b]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[4-((1-carbomethoxy-1-phenyl)methoxy)-3,5-dipropylphenylmethyl]-5,7-dimethyl-2-ethyl-3H-imidazo-[4,5-b]pyridine(137421-58-0)
• EPA Substance Registry System: 3-[4-((1-carbomethoxy-1-phenyl)methoxy)-3,5-dipropylphenylmethyl]-5,7-dimethyl-2-ethyl-3H-imidazo-[4,5-b]pyridine(137421-58-0)

Safety Data

• Hazardous Substances Data: 137421-58-0(Hazardous Substances Data)

Upstream product

• 137421-56-8 3-[4-tert-butyldimethylsilyloxy-3,5-dipropylphenylmethyl]-5,7-dimethyl-2-ethyl-3H-imidazo-[4,5-b]-pyridine 
• 160462-30-6 (4-Hydroxymethyl-2,6-dipropyl-phenoxy)-phenyl-acetic acid methyl ester 
• 137445-54-6 methyl 4-tert-butyldimethyl-silyloxy-3,5-dipropylbenzoate 
• 137421-54-6 methyl 4-tert-butyldimethylsilyloxy-3,5-di(2-propen-1-yl)benzoate 
• 137421-52-4 methyl 3-(2-propenyl)-4-(2-propenyloxy)benzoate 
• 137421-53-5 methyl 3,5-diallyl-4-hydroxybenzoate 
• 153275-16-2 (3,5-dipropyl-4-hydroxy)benzyl alcohol 
• 99-76-3 methyl 4-hydroxylbenzoate 
• 35750-24-4 methyl 4-allyloxybenzoate 
• 53596-60-4 methyl 3-allyl-4-hydroxybenzoate 
• 37167-62-7 bromo-phenyl-acetic acid methyl ester 
• 103-82-2 phenylacetic acid 
• 133240-06-9 5,7-dimethyl-2-ethyl-3H-imidazo[4,5-b]pyridine 
• 160462-31-7 (4-Bromomethyl-2,6-dipropyl-phenoxy)-phenyl-acetic acid methyl ester 

Downstream Products

• 153275-22-0 L 159882 

Relevant articles and documents

Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives

Phenoxyphenylacetic acids and derivatives of general structural formula I have endothelin STR1 antagonist activity and are therefore useful in treating cardiovascular disorders, such as hypertension, congestive heart failure, postischemic renal failure, vasospasm, cerebral and cardiac ischemia, myocardial infarction, inflammatory diseases, Raynaud's disease, and endotoxic shock, and asthma.

(Dipropylphenoxy)phenylacetic acids: A new generation of nonpeptide angiotensin II receptor antagonists

-